Hospira Vincristine Sulphate 5 mg/5 mL Injection vial (preserved)

Land: Australië

Taal: Engels

Bron: Department of Health (Therapeutic Goods Administration)

Werkstoffen:

vincristine sulfate, Quantity: 1 mg/mL

Beschikbaar vanaf:

Hospira Australia Pty Ltd

INN (Algemene Internationale Benaming):

Vincristine sulfate

farmaceutische vorm:

Injection, solution

Samenstelling:

Excipient Ingredients: benzyl alcohol; mannitol; water for injections

Toedieningsweg:

Intravenous

Eenheden in pakket:

5 x 5 mL pack

klasse:

Medicine Listed (Export Only)

Prescription-type:

(S1) This Schedule is intentionally blank

therapeutische indicaties:

Vincristine Sulphate Injection is used in the treatment of cancers of the blood (eg. leukaemia or lymphomas), breast, head and neck or lung. It may be used to treat multiple myeloma (a cancer of plasma cells) and it may also be used in the treatment of some cancers in children. It may be used in a blood disorder known as idiopathic thrombocytopenic purpura (ITP) after other treatments have not been successful. Vincristine Sulphate Injection may be given alone or in combination with other anti-cancer medicines.

Product samenvatting:

Visual Identification: A clear colourless solution; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 18 Months; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Autorisatie-status:

Licence status A

Autorisatie datum:

2011-11-02